FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/06/2023
Back to search
Official data from USPTO
M PHERECYDES PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
03/06/2023
Classification
Registered
Trademark type
Combined
Nice classes
5, 10, 42
Filing date
06/04/2021
Registration date
10/25/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/25/2022
Last transaction
10/25/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
FR
Examiner
HARMON, RAYMOND
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a gray design of a hexagon that is incomplete at the bottom, connected to a stylized letter "M" by a vertical chevron-shaped line. To the right of the design is the large stylized purple wording "PHERECYDES" above the smaller gray stylized wording "PHARMA".
Holders and representatives
Holders
P. P. (pessoa física)
Representatives
Leo M. Loughlin Rothwell, Figg, Ernst & Manbeck
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary productspharmaceutical preparations for the treatment of viral diseasesplant extracts for veterinary and pharmaceutical purposes; pharmaceutical preparations for the treatment or prevention of bacterial diseases; antibacterial substances for medical useantibacterial pharmaceuticalsantibacterial soap; diagnostic agents for medical use; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; antibodies for medical or veterinary usediagnostic kids consisting primarily of monoclonal antibodies for use in disease testing; hygienic products for medicinedisinfectants for hygiene purposesantibacterial soap; chemical preparations for medical or pharmaceutical usefor the treatment of bacterial infections; bacterial and bacteriological preparations for medical or veterinary use; bactericides pertaining to the pharmaceutical trade; fungicides pertaining to the pharmaceutical trade; germicides pertaining to the pharmaceutical trade; virucides pertaining to the pharmaceutical trade; biocides pertaining to the pharmaceutical trade; sporicides pertaining to the pharmaceutical trade; levuricides pertaining to the pharmaceutical trade; mycobactericides pertaining to the pharmaceutical trade; media for bacteriological cultures; microbicides; preparations of microorganisms for medical and veterinary use
Class 10
Analysis devices for identification of bacteria for medical use; surgicalmedicaldental and veterinary apparatus and instrumentssurgical apparatus and instruments for medical usemedical imaging apparatusultrasound apparatus for veterinary use; bacteria sampling apparatussample preparation device for medical diagnostic uses; Medical instruments for analyzing and identifying bacteriaapparatus used for the study of bacterial disorders; drug delivery devices sold emptyapplicators for anti-bacterial preparations
Class 42
Medical and pharmacological research services; scientific research in bacteriology; chemical and microbiological laboratory services; research and development in the field of chemistrymicrobiologyair flowsagri-foodstuffsbiologybacteriology; consultancy with respect to pharmaceutical research and development; consultancy with respect to bacteriology research; medical and scientific researchconducting clinical trials for others; medical and scientific researchcarrying out clinical trials for others; environmental testing and inspection servicesauditing relating to airwater and surface hygienerelating to sanitary risks and chemical or microbiological contamination; engineering worksurveying ; consultancy with respect to bacteriology; research and testing services in the fields of bacteriology and virology; scientific and technological servicesscientific and medical research workparticularly for identifying and characterizing active materials for infectious disease treatment; development of pharmaceutical treatment products; medical and scientific researchconducting preclinical or clinical studies and providing scientific support of preclinical or clinical studies
Publications
History of USPTO decisions and trademark events.
29 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/14/2023
FIMP
FINAL DISPOSITION PROCESSED
02/14/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/14/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/14/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/14/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/14/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/25/2022
GPNX
NOTIFICATION PROCESSED BY IB
08/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/09/2022
PUBO
PUBLISHED FOR OPPOSITION
08/09/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/20/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/20/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/20/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2022
RFNT
REFUSAL PROCESSED BY IB
04/18/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/31/2022
RFRR
REFUSAL PROCESSED BY MPU
03/31/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/03/2022
CNRT
NON-FINAL ACTION WRITTEN
03/02/2022
DOCK
ASSIGNED TO EXAMINER
02/22/2022
MAFR
APPLICATION FILING RECEIPT MAILED
10/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/23/2021
Continuous trademark protection
Get notified about every new filing that threatens M PHERECYDES PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.